Correlation Between Kymera Therapeutics and Bright Minds
Can any of the company-specific risk be diversified away by investing in both Kymera Therapeutics and Bright Minds at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kymera Therapeutics and Bright Minds into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kymera Therapeutics and Bright Minds Biosciences, you can compare the effects of market volatilities on Kymera Therapeutics and Bright Minds and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kymera Therapeutics with a short position of Bright Minds. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kymera Therapeutics and Bright Minds.
Diversification Opportunities for Kymera Therapeutics and Bright Minds
0.12 | Correlation Coefficient |
Average diversification
The 3 months correlation between Kymera and Bright is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Kymera Therapeutics and Bright Minds Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bright Minds Biosciences and Kymera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kymera Therapeutics are associated (or correlated) with Bright Minds. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bright Minds Biosciences has no effect on the direction of Kymera Therapeutics i.e., Kymera Therapeutics and Bright Minds go up and down completely randomly.
Pair Corralation between Kymera Therapeutics and Bright Minds
Given the investment horizon of 90 days Kymera Therapeutics is expected to under-perform the Bright Minds. But the stock apears to be less risky and, when comparing its historical volatility, Kymera Therapeutics is 48.59 times less risky than Bright Minds. The stock trades about -0.01 of its potential returns per unit of risk. The Bright Minds Biosciences is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest 117.00 in Bright Minds Biosciences on August 29, 2024 and sell it today you would earn a total of 3,735 from holding Bright Minds Biosciences or generate 3192.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kymera Therapeutics vs. Bright Minds Biosciences
Performance |
| Timeline |
| Kymera Therapeutics |
| Bright Minds Biosciences |
Kymera Therapeutics and Bright Minds Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kymera Therapeutics and Bright Minds
The main advantage of trading using opposite Kymera Therapeutics and Bright Minds positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kymera Therapeutics position performs unexpectedly, Bright Minds can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bright Minds will offset losses from the drop in Bright Minds' long position.| Kymera Therapeutics vs. Bright Minds Biosciences | Kymera Therapeutics vs. HP Inc | Kymera Therapeutics vs. Intel | Kymera Therapeutics vs. Chevron Corp |
| Bright Minds vs. Revelation Biosciences | Bright Minds vs. Zura Bio Limited | Bright Minds vs. Phio Pharmaceuticals Corp | Bright Minds vs. ZyVersa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |